Companies Dominating the Antidepressants Landscape
- AbbVie Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Alkermes
- Sun Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- F. Hoffmann-La Roche Ltd.
- AstraZeneca PLC
- GlaxoSmithKline plc
- Bristol-Myers Squibb Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Antidepressants Market in 2025 is estimated at USD 19.06 billion.
The global market size was around USD 18.12 billion in 2024 and is likely to expand at a CAGR of more than 6.5%, surpassing USD 41.09 billion revenue by 2037.
North America is expected to reach majority share by 2037, fueled by major depressive disorder among adults, an increasing frequency of mental disorder diagnoses, and rising healthcare expenditures.
The major players in the market include AbbVie Inc., Alkermes, Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, Pfizer Inc., Teva Pharmaceuticals Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company.
